PE20040172A1 - Imidazolinilmetil aralquilsulfonamidas - Google Patents
Imidazolinilmetil aralquilsulfonamidasInfo
- Publication number
- PE20040172A1 PE20040172A1 PE2003000388A PE2003000388A PE20040172A1 PE 20040172 A1 PE20040172 A1 PE 20040172A1 PE 2003000388 A PE2003000388 A PE 2003000388A PE 2003000388 A PE2003000388 A PE 2003000388A PE 20040172 A1 PE20040172 A1 PE 20040172A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- methyl
- hydrogen
- aralkylsulphonamides
- methanosulfamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
SE REFIERE A DERIVADOS DE IMIDAZOLINILMETIL ARALQUILSULFONAMIDAS DE FORMULA I DONDE R1 ES ALQUILO, NR7R8; R7 Y R8 SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO; R2 ES HIDROGENO O ALQUILO; R3 A R6 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO, HALURO, ENTRE OTROS; R14 ES HIDROGENO, ALQUILO O -OR15; R15 ES HIDROGENO, ALQUILO INFERIOR O UN GRUPO PROTECTOR HIDROXI. SON COMPUESTOS PREFERIDOS:N-[4-(4,5-DIHIDRO-1H-IMIDAZOL-2-ILMETIL)-FENIL]-METANOSULFAMIDA,N-[4-(4,5-DIHIDRO-1H-IMIDAZOL-2-ILMETIL)-2-METOXI-FENIL]-METANOSULFAMIDA,N-[4-(4,5-DIHIDRO-1H-IMIDAZOL-2-ILMETIL)-2-METILO-FENIL]-METANOSULFAMIDA, ENTRE OTROS. EL COMPUESTO DE FORMULA I ES AGONISTA DEL RECEPTOR ADRENERGICO O1A/L Y ES UTIL PARA EL TRATAMIENTO DE INCONTINENCIA, DISFUNCION SEXUAL, CONGESTION NASAL
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37470002P | 2002-04-23 | 2002-04-23 | |
US37877502P | 2002-05-08 | 2002-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20040172A1 true PE20040172A1 (es) | 2004-04-08 |
Family
ID=29273005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2003000388A PE20040172A1 (es) | 2002-04-23 | 2003-04-16 | Imidazolinilmetil aralquilsulfonamidas |
Country Status (23)
Country | Link |
---|---|
US (2) | US6756395B2 (es) |
EP (1) | EP1501817A1 (es) |
JP (1) | JP4362379B2 (es) |
KR (1) | KR100696561B1 (es) |
CN (1) | CN1296365C (es) |
AR (1) | AR039319A1 (es) |
AU (1) | AU2003227623B2 (es) |
BR (1) | BR0309668A (es) |
CA (1) | CA2483345C (es) |
HK (1) | HK1080463A1 (es) |
HR (1) | HRP20040951A2 (es) |
IL (1) | IL164676A0 (es) |
MX (1) | MXPA04010315A (es) |
MY (1) | MY139228A (es) |
NO (1) | NO20044531L (es) |
NZ (1) | NZ535823A (es) |
PA (1) | PA8571401A1 (es) |
PE (1) | PE20040172A1 (es) |
PL (1) | PL373322A1 (es) |
RU (1) | RU2318814C2 (es) |
TW (1) | TW200306807A (es) |
UY (1) | UY27770A1 (es) |
WO (1) | WO2003091236A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003227623B2 (en) * | 2002-04-23 | 2010-05-20 | F. Hoffmann-La Roche Ag | Imidazolinylmethyl aralkylsulfonamides |
WO2005063678A1 (ja) * | 2003-12-26 | 2005-07-14 | Daiichi Pharmaceutical Co., Ltd | フェニル酢酸誘導体の製造方法 |
WO2009098135A1 (en) * | 2008-02-04 | 2009-08-13 | F. Hoffmann-La Roche Ag | Novel imidazolinylmethyl aryl sulfonamides |
BRPI0906982A2 (pt) * | 2008-02-04 | 2015-07-21 | Hoffmann La Roche | N-[3-bromo-2-cloro-4-(4,5-di-hidro-ih-imidazol-2-ilmetil )-fenil]-metanossulfonamida como agonista parcial adrenégico alfa-1 a para o tratamento de incontinência |
EP2238115B1 (en) * | 2008-02-04 | 2011-11-02 | F. Hoffmann-La Roche AG | Novel imidazolinylmethyl aryl sulfonamides |
CA2711728A1 (en) * | 2008-02-04 | 2009-07-13 | F. Hoffmann-La Roche Ag | Novel imidazolinylmethyl aryl sulfonamides |
WO2009100120A2 (en) | 2008-02-04 | 2009-08-13 | Neurogen Corporation | Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines |
JP4168086B1 (ja) * | 2008-04-16 | 2008-10-22 | 国立大学法人福井大学 | イミダゾリン誘導体 |
CN103664845B (zh) * | 2013-12-27 | 2016-02-10 | 湖南欧亚生物有限公司 | 一种Plk激酶抑制剂药物中间体7-氨基-2,3-二氢苯并呋喃-4-甲酸的制备方法 |
CN103853429B (zh) * | 2014-03-14 | 2018-01-23 | 联想(北京)有限公司 | 信息处理方法、信息处理装置及电子设备 |
CN105693524A (zh) * | 2014-11-28 | 2016-06-22 | 浙江省化工研究院有限公司 | 一种硝基化合物的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3660423A (en) * | 1970-02-13 | 1972-05-02 | Dow Chemical Co | 2-(substituted benzyl)methyl-2-imidazolines |
AU3115471A (en) | 1970-07-22 | 1973-01-18 | Merck & Co Inc | Chemical processes and products |
SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
TW405272B (en) | 1997-06-25 | 2000-09-11 | Sony Corp | Method and apparatus for growth of a nitride III-V compound semiconductor |
GB9910110D0 (en) * | 1999-04-30 | 1999-06-30 | Glaxo Group Ltd | Chemical compounds |
US6323231B1 (en) * | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
US6602897B2 (en) * | 2000-10-14 | 2003-08-05 | Boehringer Ingelheim Pharma Kg | m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
US20020169193A1 (en) * | 2001-02-10 | 2002-11-14 | Pascale Pouzet | Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence |
AU2003227623B2 (en) * | 2002-04-23 | 2010-05-20 | F. Hoffmann-La Roche Ag | Imidazolinylmethyl aralkylsulfonamides |
-
2003
- 2003-04-15 AU AU2003227623A patent/AU2003227623B2/en not_active Ceased
- 2003-04-15 PL PL03373322A patent/PL373322A1/xx not_active Application Discontinuation
- 2003-04-15 KR KR1020047016958A patent/KR100696561B1/ko not_active IP Right Cessation
- 2003-04-15 WO PCT/EP2003/003904 patent/WO2003091236A1/en active Application Filing
- 2003-04-15 NZ NZ535823A patent/NZ535823A/en not_active IP Right Cessation
- 2003-04-15 MX MXPA04010315A patent/MXPA04010315A/es active IP Right Grant
- 2003-04-15 JP JP2003587796A patent/JP4362379B2/ja not_active Expired - Fee Related
- 2003-04-15 RU RU2004134326/04A patent/RU2318814C2/ru not_active IP Right Cessation
- 2003-04-15 CA CA2483345A patent/CA2483345C/en not_active Expired - Fee Related
- 2003-04-15 CN CNB038089238A patent/CN1296365C/zh not_active Expired - Fee Related
- 2003-04-15 EP EP03725029A patent/EP1501817A1/en not_active Withdrawn
- 2003-04-15 BR BR0309668-8A patent/BR0309668A/pt not_active IP Right Cessation
- 2003-04-16 PE PE2003000388A patent/PE20040172A1/es not_active Application Discontinuation
- 2003-04-16 TW TW092108802A patent/TW200306807A/zh unknown
- 2003-04-21 AR ARP030101352A patent/AR039319A1/es unknown
- 2003-04-21 PA PA20038571401A patent/PA8571401A1/es unknown
- 2003-04-22 MY MYPI20031496A patent/MY139228A/en unknown
- 2003-04-22 UY UY27770A patent/UY27770A1/es not_active Application Discontinuation
- 2003-04-22 US US10/421,119 patent/US6756395B2/en not_active Expired - Fee Related
-
2004
- 2004-04-13 US US10/823,012 patent/US7407980B2/en not_active Expired - Fee Related
- 2004-10-12 HR HR20040951A patent/HRP20040951A2/hr not_active Application Discontinuation
- 2004-10-18 IL IL16467604A patent/IL164676A0/xx unknown
- 2004-10-21 NO NO20044531A patent/NO20044531L/no not_active Application Discontinuation
-
2006
- 2006-01-05 HK HK06100195A patent/HK1080463A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0309668A (pt) | 2005-03-01 |
US20030229130A1 (en) | 2003-12-11 |
PL373322A1 (en) | 2005-08-22 |
JP2005534628A (ja) | 2005-11-17 |
MXPA04010315A (es) | 2005-06-08 |
HK1080463A1 (en) | 2006-04-28 |
NO20044531L (no) | 2004-11-19 |
MY139228A (en) | 2009-08-28 |
WO2003091236A1 (en) | 2003-11-06 |
US7407980B2 (en) | 2008-08-05 |
EP1501817A1 (en) | 2005-02-02 |
AU2003227623B2 (en) | 2010-05-20 |
PA8571401A1 (es) | 2004-02-07 |
CA2483345C (en) | 2010-12-21 |
CA2483345A1 (en) | 2003-11-06 |
HRP20040951A2 (hr) | 2006-06-30 |
CN1646516A (zh) | 2005-07-27 |
CN1296365C (zh) | 2007-01-24 |
KR100696561B1 (ko) | 2007-03-19 |
US20040214875A1 (en) | 2004-10-28 |
RU2004134326A (ru) | 2006-01-27 |
UY27770A1 (es) | 2003-10-31 |
IL164676A0 (en) | 2005-12-18 |
TW200306807A (en) | 2003-12-01 |
AR039319A1 (es) | 2005-02-16 |
RU2318814C2 (ru) | 2008-03-10 |
NZ535823A (en) | 2007-07-27 |
US6756395B2 (en) | 2004-06-29 |
JP4362379B2 (ja) | 2009-11-11 |
AU2003227623A1 (en) | 2003-11-10 |
KR20040102151A (ko) | 2004-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2386626C2 (ru) | 1a, 5a-ТЕТРАГИДРО-S-ТИАЦИКЛОПРОПА[a]ПЕНТАЛЕНЫ:ТРИЦИКЛИЧЕСКИЕ ПРОИЗВОДНЫЕ ТИОФЕНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ S1P1/EDG1 | |
PE20001467A1 (es) | Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina | |
PE20010683A1 (es) | Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas | |
PE20040172A1 (es) | Imidazolinilmetil aralquilsulfonamidas | |
PE20021094A1 (es) | Derivados de ciclohexano-1,4-diamina sustituidos | |
PE20010741A1 (es) | Derivados de piperazina como antagonistas de taquicininas | |
PE20011030A1 (es) | Combinaciones farmaceuticas que comprenden tegaserod y omeprazol | |
PE20030238A1 (es) | Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales y neuronales | |
PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
EA200700047A1 (ru) | Новые алкильные производные в качестве метаботропных рецепторов глутамата | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
YU1199A (sh) | Derivati benzosulfona | |
PE20001483A1 (es) | Acidos oxamicos y derivados como ligandos de receptores tiroideos | |
DK1173433T3 (da) | Cyanopyrroler som progesteronreceptoragonister | |
PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
PE20040775A1 (es) | DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2 | |
RU2323927C2 (ru) | Производные 1-сульфонил-4-аминоалкоксииндола и фармацевтическая композиция, обладающая активностью модулятора 5-нт6 рецептора | |
PE20030568A1 (es) | Derivados de piperazina como antagonistas de receptores ccr1 | |
PE20061049A1 (es) | Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida como antagonistas del receptor de vanilloides tipo 1 (vr1) | |
ATE390922T1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
PE20051152A1 (es) | Antagonistas del receptor de acetilcolina muscarinico m3 | |
PE20020258A1 (es) | Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina 1 (nk-1) | |
EP1798227A4 (en) | SEROTONIN 5-HT3 RECEPTOR AGONIST | |
PE20050460A1 (es) | COMPUESTOS HETEROCICLICOS COMO ANTAGONISTAS CaSR (RECEPTOR SENSIBLE AL CALCIO) | |
PE20001648A1 (es) | Derivados de 3-amino-3-arilpropan-1-ol y procedimientos de preparacion de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |